Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal <sup>18</sup>F-FES PET/CT

<div><sup>18</sup>F-FES microPET/CT imaging of ER-positive ZR-75-1 tumor mice on days 0, 3, 14, and 21 after treatment. The tumors were indicated by arrows.</div>

Contrast Media & Molecular Imaging

fig3

Figure 3

Figure 3: Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal <sup>18</sup>F-FES PET/CT 

Figure 3 | Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal 18F-FES PET/CT 